BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34304907)

  • 21. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
    Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
    Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Najjari Jamal D; Pötter R; Haie-Meder C; Lindegaard JC; Juergenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Tanderup K; Kirchheiner K;
    Radiother Oncol; 2018 Jun; 127(3):449-455. PubMed ID: 29631933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography.
    Rajasooriyar C; Van Dyk S; Lindawati M; Bernshaw D; Kondalsamy-Chennakesavan S; Narayan K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1532-7. PubMed ID: 23027037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance image-guided brachytherapy for cervical cancer : Prognostic factors for survival.
    Kim YJ; Kim JY; Kim Y; Lim YK; Jeong J; Jeong C; Kim M; Lim MC; Seo SS; Park SY
    Strahlenther Onkol; 2016 Dec; 192(12):922-930. PubMed ID: 27734106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
    Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
    Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
    Chopra S; Engineer R; Shah S; Shukla R; Dora T; Gupta P; Paul SN; Popat P; Swamidas J; Mahantshetty U; Varghese L; Gupta S; Rangrajan V; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):310-319. PubMed ID: 31682968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
    Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.
    Kim H; Park W; Cho WK
    J Radiat Res; 2020 May; 61(3):479-486. PubMed ID: 32211854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer.
    Wakatsuki M; Ohno T; Kato S; Ando K; Noda SE; Kiyohara H; Shibuya K; Karasawa K; Kamada T; Nakano T
    J Radiat Res; 2014 Jan; 55(1):139-45. PubMed ID: 23912599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy.
    Lee WH; Kim GE; Kim YB
    J Gynecol Oncol; 2022 Sep; 33(5):e59. PubMed ID: 35882603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative image-guided brachytherapy in early stage cervical cancers.
    Escande A; Mazeron R; Gouy S; Bentivegna E; Maroun P; Fahra G; Oberlander AS; Dumas I; Castelnau-Marchand P; Deutsch E; Morice P; Haie-Meder C; Chargari C
    Radiother Oncol; 2016 Sep; 120(3):455-459. PubMed ID: 27614680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
    Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
    Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
    K Jensen NB; Pötter R; Spampinato S; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Van der Steen-Banasik E; Van Limbergen E; Sundset M; Pieters BR; Nout RA; Kirisits C; Kirchheiner K; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):688-700. PubMed ID: 33068689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.